← Open Payments lookup

KAYLA SMITH: Open Payments

NPI 1457132870 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,457 in 83 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,587 · 2025 $1,457

Food & beverage: $1,457
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.25$396
Bayer Healthcare Pharmaceuticals Inc.16$229
Travere Therapeutics, Inc.9$177
Otsuka America Pharmaceutical, Inc.9$151
Vifor Pharma, Inc.5$95
Amgen Inc.4$86
Novartis Pharmaceuticals Corporation5$85
Apellis Pharmaceuticals, Inc.2$65
GlaxoSmithKline, LLC.2$41
AstraZeneca Pharmaceuticals LP2$39

Products named: TARPEYO, Kerendia, JYNARQUE, Veltassa, KRYSTEXXA, Fabhalta, BENLYSTA, FARXIGA.

Industry payments across PA — which companies pay providers there.